Challenges in Protecting Pharmaceutical Trademarks

13 Pages Posted: 11 Jan 2022 Last revised: 18 Jul 2023

See all articles by Vitor Palmela Fidalgo

Vitor Palmela Fidalgo

University of Lisbon - Law School; CIDP - Centro de Investigação de Direito Privado | Lisbon Centre for Research in Private Law

Date Written: April 30, 2017

Abstract

With this article I intend to provide a study of pharmaceutical trademarks mainly under European Union trademark legislation. Compared to other kinds of trademarks, the pharmaceutical ones present a particular set of legal problems. Among these, I address four specific issues that I consider to be the main challenges for IP stakeholders: i) the relationship between the assessment performed by drug agencies and intellectual property offices; ii) the average consumer criteria for pharmaceutical trademarks; iii) the requirement of use regarding pharmaceutical trademarks; iv) the acquisition of reputation by pharmaceutical trademarks.

Keywords: Trade Marks; Pharmaceutical trademarks; EU Trademark

Suggested Citation

Palmela Fidalgo, Vitor, Challenges in Protecting Pharmaceutical Trademarks (April 30, 2017). GRUR Int., 4 (2017) 308, Centro de Investigação de Direito Privado (CIDP) Research Paper No. 16, Available at SSRN: https://ssrn.com/abstract=3927395 or http://dx.doi.org/10.2139/ssrn.3927395

Vitor Palmela Fidalgo (Contact Author)

University of Lisbon - Law School ( email )

Alameda da Universidade, Cidade Universitária
Lisboa, 1649-014
Portugal

CIDP - Centro de Investigação de Direito Privado | Lisbon Centre for Research in Private Law ( email )

Faculdade de Direito da Universidade de Lisboa
Alameda da Universidade
Lisbon, 1649 014
Portugal

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
118
Abstract Views
949
Rank
437,749
PlumX Metrics